Try our beta test site
Trial record 1 of 1 for:    nct00720785
Previous Study | Return to List | Next Study

Natural Killer Cells and Bortezomib to Treat Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 19, 2017 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00720785
First received: July 22, 2008
Last updated: January 27, 2017
Last verified: January 19, 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 1, 2018
  Estimated Primary Completion Date: January 1, 2018 (Final data collection date for primary outcome measure)